These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33064841)

  • 1. Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5.
    Koşaloğlu-Yalçın Z; Sidney J; Chronister W; Peters B; Sette A
    Immunology; 2021 Feb; 162(2):235-247. PubMed ID: 33064841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
    Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
    Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
    Sidney J; del Guercio MF; Southwood S; Sette A
    J Immunol; 2002 Nov; 169(9):5098-108. PubMed ID: 12391226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
    Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
    Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.
    Verreck FA; van de Poel A; Termijtelen A; Amons R; Drijfhout JW; Koning F
    Eur J Immunol; 1994 Feb; 24(2):375-9. PubMed ID: 8299686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
    Shen WJ; Zhang X; Zhang S; Liu C; Cui W
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library.
    Jüse U; van de Wal Y; Koning F; Sollid LM; Fleckenstein B
    Hum Immunol; 2010 May; 71(5):475-81. PubMed ID: 20105447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
    Jørgensen KW; Buus S; Nielsen M
    PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
    Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
    Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system.
    Paul S; Croft NP; Purcell AW; Tscharke DC; Sette A; Nielsen M; Peters B
    PLoS Comput Biol; 2020 May; 16(5):e1007757. PubMed ID: 32453790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
    Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG
    Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms.
    Rajapakse M; Schmidt B; Feng L; Brusic V
    BMC Bioinformatics; 2007 Nov; 8():459. PubMed ID: 18031584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
    Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
    Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
    Odunsi K; Ganesan T
    Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing high affinity binding to HLA-DQ2.5 by a novel peptide library based approach.
    Jüse U; Arntzen M; Højrup P; Fleckenstein B; Sollid LM
    Bioorg Med Chem; 2011 Apr; 19(7):2470-7. PubMed ID: 21382721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.